Identification of predictive genetic signatures of Cytarabine responsiveness using a 3D acute myeloid leukaemia model-Reference-Cited by-同舟云学术

Identification of predictive genetic signatures of Cytarabine responsiveness using a 3D acute myeloid leukaemia model

Published:2019-08-26 Issue:10 Volume:23 Page:7063-7077
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Xu Haiyan¹^ORCID,Muise Eric S.²,Javaid Sarah²,Chen Lan³,Cristescu Razvan⁴,Mansueto My Sam¹,Follmer Nicole⁵,Cho Jennifer²,Kerr Kimberley²,Altura Rachel⁶,Machacek Michelle⁷,Nicholson Benjamin⁵,Addona George¹,Kariv Ilona¹,Chen Hongmin¹

Affiliation:

1. Department of Pharmacology Merck & Co., Inc. Boston MA USA

2. Department of Genetics and Pharmacogenomics Merck & Co., Inc. Boston MA USA

3. Department of Strategic Planning & Research Informatics Merck & Co., Inc. Beijing China

4. Department of Precision Oncology Biomarkers Merck & Co., Inc. Boston MA USA

5. Department of Oncology Early Discovery Merck & Co., Inc. Boston MA USA

6. Department of Oncology Early Development Merck & Co., Inc. Rahway NJ USA

7. Department of Discovery Chemistry Merck & Co., Inc. Boston MA USA

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine